Amarin Corporation PLC reports results for the quarter ended March 31 - Earnings Summary

Amarin

07/05/2025 14:32

Amarin Corporation PLC AMRN.OQ reported a quarterly adjusted loss of 4 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of -40 cents.  The mean expectation of three analysts for the quarter was for a loss of 57 cents per share. Wall Street expected results to range from -74 cents to -40 cents per share.

Revenue fell 25.7% to $42.02 million from a year ago; analysts expected $50.75 million.

Amarin Corporation PLC's reported EPS for the quarter was a loss of 4 cents​.

The company reported a quarterly loss of $15.7 million.

Amarin Corporation PLC shares had risen by 13.7% this quarter and gained 5.1% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 48.2% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "sell" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "sell"

Wall Street's median 12-month price target for Amarin Corporation PLC is $13.50

This summary was machine generated from LSEG data May 7 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.57
-0.04
Beat
Dec. 31 2024
-1.07
-0.60
Beat
Sep. 30 2024
-1.00
-1.20
Missed
Jun. 30 2024
-0.75
0.00
Beat